logo
logo
  • About us
    • LTU School of Cancer Medicine
    • Our Partners
    • Our People
    • Our Corporate Publications
    • Our Policies
    • A message from our Founding Champion
  • Our Research
    • Research Programs
      • Genome Engineering and Cancer Modelling Program
        • Blood Cancer and Immunotherapy Laboratory
      • Tumour Environment and Immunology Program
        • Cancer and Inflammation Laboratory
        • Tumour Immunology Laboratory
        • Mucosal Immunity and Cancer Laboratory
        • Tissue and Tumour Immunity Laboratory
        • Tumour Microenvironment and Cancer Signaling Group
        • Cytokine and Cancer Signalling Group
      • Cancer Biology and Therapy Program
        • Oncogenic Transcription Laboratory
        • Metastasis Research Laboratory
        • Tumour Progression and Heterogeneity Laboratory
        • Cell Death and Survival Laboratory
        • Cancer Single Cell Genomics Laboratory
        • Molecular Immunology Laboratory
      • Tumour Targeting Program
        • Tumour Targeting Laboratory
        • Receptor Biology Laboratory
      • Centre for Research Excellence in Brain Cancer
      • Bioinformatics and Cancer Genomics Laboratory
    • Research Platforms
      • The ACRF Centre for Translational Cancer Therapeutics and Imaging
      • The ACRF Centre for Imaging the Tumour Environment
      • VECTRA Multi-Spectral Imaging Platform
      • Mammalian Protein Expression Facility
      • Flow Cytometry Core Facility
  • Clinical Trials
  • Latest news
  • Join our team
    • Study opportunities
    • Career opportunities
    • Volunteer Opportunities
  • Contact us
  • Support us
  • Donate now
  • Search

Month: January 2021

Monepantel preclinical investigations to continue with PharmAust

Read More

Address

Level 5, ONJ Centre
145 Studley Road
Heidelberg VIC 3084 Australia

Call us

+61 3 9496 5726

Explore

    • Home
    • About us
    • Donate
    • Our research
    • Join our team
    • Clinical trials
    • Latest news
    • Contact us
    • Privacy Policy

The Olivia Newton-John Cancer Research Institute is registered with the Australian Taxation Office as an Income Tax Exempt Charitable Entity

ONJCRI acknowledges the Traditional Owners of the land and we pay our respects to Elders past and present

Privacy Preference Center

Privacy Preferences